Training patients’ own immune cells to recognize and destroy hard-to-treat solid tumors

Children’s National Hospital’s Center for Cancer and Immunology Research, led by Catherine “Cath” Bollard, M.B.Ch.B., is forging new frontiers in cancer immunotherapy, which reprograms a patient’s own immune cells so they learn to recognize and destroy cancer cells – and just cancer cells. This short video explains the lab’s use of a novel immune-directed, T-cell therapy to treat high-risk children and young adults with solid tumors who have few therapeutic options and face uncertain futures. STAT editors chose this research paper as one of the finalists in STAT Madness 2020, a bracket-style competition to highlight the year’s best biomedical innovations.

Vote NOW for Children’s National!